Invasive electrophysiologic studies as predictor of sudden death and for treatment of patients with aborted sudden death.
Scheinman
M M
MM
Department of Medicine, University of California, San Francisco.
D000293:Adolescent; D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000328:Adult; D000368:Aged; D000638:Amiodarone / Q000627:therapeutic use; D002648:Child; D003645:Death, Sudden / Q000209:etiology; D004554:Electric Countershock; D004594:Electrophysiology; D005260:Female; D005500:Follow-Up Studies; D006321:Heart / Q000502:physiology; D006323:Heart Arrest / Q000150:complications / Q000517:prevention & control*; D006801:Humans; D008297:Male; D008875:Middle Aged; D011342:Procainamide / Q000627:therapeutic use; D011802:Quinidine / Q000627:therapeutic use; D013610:Tachycardia / Q000150:complications / Q000628:therapy*
D000319:Adrenergic beta-Antagonists; D011802:Quinidine; D011342:Procainamide; D000638:Amiodarone